Literature DB >> 22229796

Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis.

Mahmoud Reza Azarpazhooh1, Kazem Hasanpour, Mohsen Ghanbari, S A Rahim Rezaee, Baratali Mashkani, Mohammad Reza Hedayati-Moghaddam, Narges Valizadeh, Reza Farid Hosseini, Mohsen Foroghipoor, Azadeh Soltanifar, Maryam Sahebari, Keyhan Azadmanesh, Gholahossein Hassanshahi, Houshang Rafatpanah.   

Abstract

Human T-lymphotropic virus type 1 (HTLV-I) is an important global health problem in the world mainly in the endemic areas of HTLV-I infection. It was previously reported that Mashhad, in northeastern Iran, is a new endemic region of HTLV-I. The aim of this study was to examine the prevalence and phylogenetic analysis of HTLV-I in Sabzevar, located in the southeast of Mashhad. In this cross-sectional study 1445 individuals were selected by multistage cluster sampling. Serum samples were screened for anti-HTLV-I antibody using enzyme-linked immunosorbent assay (ELISA); all of the ELISA-positive samples were confirmed by polymerase chain reaction (PCR). Long terminal repeat (LTR) sequencing was carried out to determine the type of HTLV-I in Sabzevar. In the primary screening by ELISA, 26/1445 (1.8%) of those sampled were reactive for HTLV-I antibody. Twenty-four out of 26 samples were confirmed HTLV-I infection by PCR (24/1445). The overall prevalence of HTLV-I infection in Sabzevar is 1.66%. The prevalence of the virus infection in men and women was 2.42% (11/455) and 1.31% (13/989), respectively. Seroprevalence was associated with age, increasing significantly among those older than 30 years (p=0.015), and a history of surgery (p=0.002), imprisonment (p=0.018), and hospitalization (p=0.005). Three out of 24 positive HTLV-I samples were selected for sequencing and phylogenetic analysis of LTR. The results showed that HTLV-I in Sabzevar belonged to the cosmopolitan subtype. The present study showed Sabzevar is a new endemic area for HTLV-I infection. Our study emphasizes that systemic HTLV-I screening of blood donors in Sabzevar and other cities in Khorasan province is important and should be taken into account.

Entities:  

Mesh:

Year:  2012        PMID: 22229796     DOI: 10.1089/AID.2011.0248

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  24 in total

1.  Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.

Authors:  Reza Boostani; Rosita Vakili; Samane Sadat Hosseiny; Ali Shoeibi; Bahare Fazeli; Mohammad Mehdi Etemadi; Faeze Sabet; Narges Valizade; Seyed Abdolrahim Rezaee
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

2.  Altered Expression of Cell Cycle Regulators in Adult T-Cell Leukemia/ Lymphoma Patients.

Authors:  Reza Torshizi; Ehsan Ghayour Karimani; Kobra Etminani; Mohammad Mehdi Akbarin; Khadijeh Jamialahmadi; Abbas Shirdel; Hossein Rahimi; Abolghasem Allahyari; Amin Golabpour; Houshang Rafatpanah
Journal:  Rep Biochem Mol Biol       Date:  2017-10

3.  Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia/lymphoma.

Authors:  Samaneh Ramezani; Abbas Shirdel; Houshang Rafatpanah; Mohammad Mehdi Akbarin; Hanieh Tarokhian; Hossein Rahimi; Alireza Bari; Hamid Reza Jahantigh; Seyed Abdolrahim Rezaee
Journal:  Med Microbiol Immunol       Date:  2017-05-02       Impact factor: 3.402

Review 4.  Updates on the Epidemiology of the Human T-Cell Leukemia Virus Type 1 Infection in the Countries of the Eastern Mediterranean Regional Office of the World Health Organization with Special Emphasis on the Situation in Iran.

Authors:  Mohammad Reza Hedayati-Moghaddam; Reza Jafarzadeh Esfehani; Hiba El Hajj; Ali Bazarbachi
Journal:  Viruses       Date:  2022-03-23       Impact factor: 5.818

5.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

6.  Adult T-cell leukemia: a review of epidemiological evidence.

Authors:  Masako Iwanaga; Toshiki Watanabe; Kazunari Yamaguchi
Journal:  Front Microbiol       Date:  2012-09-10       Impact factor: 5.640

7.  Oncogenic Virus Infections in the General Population and End-stage Renal Disease Patients With Special Emphasis on Kaposi's Sarcoma Associated Herpes Virus (KSHV) in Northeast of Iran.

Authors:  Sanaz Ahmadi Ghezeldasht; Tahereh Hassannia; Houshang Rafatpanah; Reza Hekmat; Narges Valizadeh; Majid Ghayour Mobarhan; Seyed Abdolrahim Rezaee
Journal:  Jundishapur J Microbiol       Date:  2015-03-21       Impact factor: 0.747

8.  Seroepidemiology of human T-cell lymphotropic virus type-I in blood donors of Northeastern Iran, Sabzevar.

Authors:  Mahtab Maghsudlu; Hamidreza Safabakhsh; Parastoo Jamili
Journal:  Asian J Transfus Sci       Date:  2015 Jul-Dec

9.  Prevalence of Human T-Lymphotropic Virus Types I and II in Patients With Hematological Disorders in Isfahan, Iran.

Authors:  Mohammadreza Mahzounieh; Mohammadreza Ghorani; Ali Karimi; Batoul Pourgheysari; Razieh Nikoozad
Journal:  Jundishapur J Microbiol       Date:  2015-06-25       Impact factor: 0.747

10.  The prevalence of HTLV-1 and its Co-Infection with HCV, HBV and HIV in Hemophilic patients.

Authors:  Masood Ziaee; Mohammad Hassan Namaei; Ghodseh Azarkar
Journal:  Pak J Med Sci       Date:  2015 Sep-Oct       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.